Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
SeqOnce Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
SeqOnce Biosciences

SeqOnce Biosciences

Seed

SeqOnce Biosciences: A life science company specializing in DNA testing and sample preparation technology.

HQ
Pasadena, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

SeqOnce Biosciences, founded in California, is a life science company dedicated to advancing DNA testing and sample preparation technology. Their core mission is to enhance the accuracy and efficiency of genetic testing through innovative solutions. The company offers a range of products, including qPCR panels for respiratory pathogens, urinary tract microbiota detection, antibiotic resistance gene detection, and NGS DNA library preparation kits like RhinoSeq. SeqOnce Biosciences primarily serves the healthcare and research markets, focusing on providing reliable and rapid diagnostic tools.

Notable affiliated individuals and investors include experts in genomics and biotechnology, though specific names are not publicly highlighted. Key achievements of SeqOnce Biosciences include the development of advanced qPCR panels and the RhinoSeq NGS DNA library prep kit, which have significantly impacted the efficiency of genetic testing processes. The company's contributions have improved diagnostic accuracy and speed, making a substantial impact on healthcare diagnostics and research methodologies.

SeqOnce Biosciences - Similar Companies

RealSeq Biosciences logo

RealSeq Biosciences

Quintarabio logo

Quintarabio

Paragon Genomics logo

Paragon Genomics

BillionToOne logo

BillionToOne

billiontoone.com

Bioinfoexperts logo

Bioinfoexperts

bioinfox.com

Parse Biosciences logo

Parse Biosciences

Karius logo

Karius

kariusdx.com

GeneCapture logo

GeneCapture

genecapture.com

Aperiomics logo

Aperiomics

SeQure Dx logo

SeQure Dx

sequre-dx.com

Element Biosciences logo

Element Biosciences

PathogenDx logo

PathogenDx

pathogendx.com

YourBio Health logo

YourBio Health

yourbiohealth.com

Mission Bio logo

Mission Bio

Accelevir Diagnostics logo

Accelevir Diagnostics

SeqOnce Biosciences - Quick Facts

Who are SeqOnce Biosciences' competitors?

Companies similar to SeqOnce Biosciences include RealSeq Biosciences, Quintarabio, Paragon Genomics and BillionToOne.

When was SeqOnce Biosciences founded?

SeqOnce Biosciences was founded in 2014.

Where is SeqOnce Biosciences' headquarters located?

SeqOnce Biosciences' headquarters is located in Pasadena, CA, US.

How much has SeqOnce Biosciences raised to-date?

As of Oct 26, 2018, SeqOnce Biosciences has raised a total of $1.2M (USD).

How many employees does SeqOnce Biosciences have?

SeqOnce Biosciences has 16 employees as of Feb 5, 2024.

SeqOnce Biosciences - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • DNA Testing
  • Sample Preparation
Tags
  • API
  • Data
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified